Wen Wee Ma Selected Research

Wen Wee Ma Research Topics

Disease

41	Neoplasms (Cancer) 04/2024 - 09/2008
22	Pancreatic Neoplasms (Pancreatic Cancer) 02/2024 - 12/2010
15	Adenocarcinoma 02/2024 - 12/2010
5	Colorectal Neoplasms (Colorectal Cancer) 04/2024 - 01/2013
5	Fatigue 04/2024 - 12/2010
4	Hepatocellular Carcinoma (Hepatoma) 04/2024 - 02/2015
4	Disease Progression 01/2022 - 10/2013
4	Neutropenia 10/2013 - 09/2008
3	Exanthema (Rash) 09/2017 - 08/2013
3	Diarrhea 01/2017 - 08/2013
3	Nausea 01/2017 - 08/2013
2	Cholangiocarcinoma 02/2024 - 01/2022
2	Biliary Tract Neoplasms (Biliary Tract Cancer) 01/2021 - 01/2019
2	Mucositis 01/2017 - 09/2008
2	Vomiting 01/2017 - 10/2016
2	Melanoma (Melanoma, Malignant) 10/2016 - 02/2015
1	Embolism (Embolus) 04/2024
1	Dehydration (Water Stress) 04/2024
1	Asthenia 04/2024
1	Liver Neoplasms (Liver Cancer) 02/2024
1	Neoplasm Metastasis (Metastasis) 02/2024
1	Hematologic Neoplasms (Hematological Malignancy) 11/2023
1	Microsatellite Instability 01/2023
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 11/2022
1	Thrombocytopenia 3 01/2022
1	Body Weight (Weight, Body) 01/2022
1	Glioma (Gliomas) 01/2022
1	Glioblastoma (Glioblastoma Multiforme) 01/2022
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2020
1	Pathologic Complete Response 12/2017
1	Rectal Neoplasms (Rectal Cancer) 12/2017
1	Turcot syndrome 05/2017

Drug/Important Bio-Agent (IBA)

13	Gemcitabine FDA Link 04/2024 - 04/2012
6	Capecitabine (Xeloda)FDA Link 04/2024 - 12/2010
5	Biomarkers (Surrogate Marker)IBA 04/2024 - 08/2013
5	Paclitaxel (Taxol)FDA LinkGeneric 02/2024 - 10/2013
4	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2024 - 01/2021
3	Proteins (Proteins, Gene)FDA Link 05/2023 - 09/2011
3	Immune Checkpoint InhibitorsIBA 01/2023 - 05/2017
3	Irinotecan (Camptosar)FDA LinkGeneric 01/2022 - 01/2013
3	Erlotinib Hydrochloride (CP 358,774)FDA Link 09/2017 - 12/2010
3	EnzymesIBA 01/2017 - 12/2010
3	130-nm albumin-bound paclitaxelIBA 07/2016 - 10/2013
2	Tyrosine Kinase InhibitorsIBA 04/2024 - 08/2013
2	Circulating Tumor DNAIBA 02/2024 - 10/2023
2	Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA 02/2024 - 11/2023
2	AntibodiesIBA 05/2023 - 11/2019
2	pembrolizumabIBA 01/2023 - 01/2022
2	Cetuximab (Erbitux)FDA Link 11/2019 - 01/2013
2	sonidegibIBA 11/2019 - 01/2019
2	Fluorouracil (Carac)FDA LinkGeneric 01/2017 - 04/2015
2	Sorafenib (BAY 43-9006)FDA Link 02/2015 - 02/2015
2	pazopanib FDA Link 08/2013 - 08/2013
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 04/2024
1	nintedanibIBA 04/2024
1	Bevacizumab (Avastin)FDA Link 04/2024
1	ribociclibIBA 04/2024
1	Glycogen Synthase (Synthase I)IBA 11/2023
1	Chimeric Antigen ReceptorsIBA 05/2023
1	Monoclonal AntibodiesIBA 05/2023
1	EpitopesIBA 05/2023
1	AntigensIBA 05/2023
1	blinatumomabIBA 05/2023
1	matrigelIBA 01/2023
1	Culture MediaIBA 11/2022
1	methanesulfonic acid (methanesulfonate)IBA 01/2022
1	Lomustine (CCNU)FDA Link 01/2022
1	Dosage Forms (Dosage Form)IBA 01/2022
1	N-acetyltalosaminuronic acid (NAT)IBA 01/2022
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2022
1	JNK Mitogen-Activated Protein KinasesIBA 12/2021
1	ceritinibIBA 12/2021
1	Anaplastic Lymphoma KinaseIBA 12/2021
1	Proto-Oncogene Proteins c-metIBA 12/2021
1	BilirubinIBA 01/2021
1	Carboplatin (JM8)FDA LinkGeneric 01/2021
1	Peptide Receptors (Peptide Receptor)IBA 01/2020
1	Radioisotopes (Radionuclides)IBA 01/2020
1	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2020
1	Drug CombinationsIBA 11/2019
1	Growth Factor ReceptorsIBA 11/2019
1	4- amino- 5- fluoro- 3- (5- (4- methylpiperazin- 1- yl)- 1H- benzimidazol- 2- yl)quinolin- 2(1H)- oneIBA 01/2019
1	Smoothened ReceptorIBA 01/2019
1	LigandsIBA 01/2019
1	HhAntag691IBA 01/2019
1	4- imino- 1,3- diazabicyclo(3.1.0)hexan- 2- oneIBA 01/2018
1	CotinineIBA 09/2017
1	Nicotine FDA Link 09/2017

Therapy/Procedure

23	Therapeutics 11/2023 - 09/2011
16	Drug Therapy (Chemotherapy) 02/2024 - 08/2015
6	Neoadjuvant Therapy 03/2022 - 12/2017
4	Immunotherapy 11/2023 - 08/2015
2	Lab-On-A-Chip Devices 11/2023 - 01/2023
2	Combination Drug Therapy (Combination Chemotherapy) 01/2020 - 06/2012
1	Liver Transplantation 02/2024
1	Cell- and Tissue-Based Therapy (Cell Therapy) 05/2023
1	Precision Medicine 11/2022
1	Oral Administration 01/2022
1	Immunomodulation 01/2022
1	Adjuvant Chemotherapy 12/2017